Menopausal hot flashes drugs are used to reduce hot flashes, which is a form of temperature dysfunction that occurs due to changes in gonadal hormones. A hot flash is a sudden feeling of warmth, which is usually most intense over the chest, neck, and face. Hot flashes cause redness of the skin and excessive sweating. Hot flashes generally occur due to menopause when menstrual periods become irregular and eventually stop. Hot flashes cause due to changes in reproductive hormones which become more sensitive to slight changes in body temperature.This growth is primarily driven by Increasing Incidence of Menopausal Hot Flashes and High prevalence of fluctuating estrogen levels and depleting musculoskeletal health among women.
Globally, a noticeable market trend is evident Rising R&D in Treatment Options that Target the Brain’s Thermostat to Reduce the Incidence of Hot Flashes in Women. Major Players, such as Pfizer Inc. (United States), Novartis AG (Switzerland), Novo Nordisk A/S (Denmark), Allergan plc (Ireland), Teva Pharmaceutical Industries Ltd. (Ireland), Mylan N.V. (United States), Hisamitsu Pharmaceutical Co., Inc. (Japan), Merck & Co., Inc. (United States), GlaxoSmithKline plc (United Kingdom), TherapeuticsMD, Inc (United States) and Bayer (Germany) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.
Key Developments in the Market:
On 6th August 2019, Astellas Pharma Inc. has announced the dosing of the first patient in the SKYLIGHT 1 Phase 3 pivotal trial for fezolinetant, an investigational oral, non-hormonal compound being studied for the treatment of moderate-to-severe vasomotor symptoms (VMS) – i.e., hot flashes and night sweats associated with menopause.
On 14th March 2018, Imperial College London has introduced a new class of experimental drugs that reduces hot flushes in menopausal women.
- Increasing Incidence of Menopausal Hot Flashes
- High prevalence of fluctuating estrogen levels and depleting musculoskeletal health among women
- Rising R&D in Treatment Options that Target the Brain’s Thermostat to Reduce the Incidence of Hot Flashes in Women
- Increased Risk of Breast Cancer with Estrogen-Progestin Use
Technological Advancements in the Development of New Drugs
Strict Government Regulations
AdvanceMarketAnalytics follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.
Customization of the Report:
AMA Research & Media features not only specific market forecasts, but also include significant value-added commentary on:
Technological Trends and Innovations
Regulatory Trends & Policies
Market Maturity Indicators
Market Share Movements
Growth Drivers and Constraints
New Entrants into the Market & Entry/Exit Barriers
Supporting Company Financial and Cash Flow Planning
Open Up New Markets
To Seize Powerful Market Opportunities
Key Decision in Planning and to Further Expand Market Share
Identify Key Business Segments, Market Proposition & Gap Analysis